White House COVID-19 coordinator Jeff Zients said on Tuesday that the US has more than enough vaccine from Pfizer Inc and Moderna Inc to keep up the pace of vaccinations during a pause in the use of Johnson & Johnson’s shot.
US federal health agencies on Tuesday recommended pausing administering J&J’s COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after getting the shot, dealing a setback in efforts to tackle the pandemic.
“We have more than enough supply of Pfizer and Moderna vaccines to continue the current pace of about 3 million shots per day, and that puts us well on pace to meet the President’s goal of 200 million shots by his first 100 days in office,” Zients said.
US infectious disease official Dr. Anthony Fauci said on Tuesday that the pause on J&J’s vaccine is likely to last days or weeks, and that he could not rule out that the review would lead to a full stoppage of the vaccine.
Stalled Pfizer deal clouds Israel’s hopes of swift COVID-19 herd immunityA bid to secure more Pfizer/BioNTech doses for Israel’s world-beating vaccination drive has become mired in political squabbles, just as its ... Coronavirus
OPEC raises 2021 oil demand growth forecast on hopes COVID-19 impact subsidesOPEC on Tuesday raised its forecast for growth in world oil demand this year on hopes the pandemic will subside, providing help for the group and its ... Coronavirus
Egyptians celebrate a more normal Ramadan despite COVID-19 worriesEgyptians are celebrating the start of the Islamic holy month of Ramadan in more normal conditions despite concerns about a rise in coronavirus cases ... Coronavirus